Deletion of GSDMD in macrophages significantly attenuated the therapeutic efficacy of NDGA on DSS-induced colitis, as evidenced by the absence of significant differences in survival rates, weight loss, colon shortening, and histological scores between the DSS+PBS and DSS+NDGA groups (Figure 8(b-h)). The gene discussed is GSDMD; the disease is colitis.